SAN ANTONIO -- Preoperative radiotherapy (RT) plus PD-1 inhibitor pembrolizumab (Keytruda) significantly increased immune ...

"What you have said is a terrible, terrible distortion of all the facts." -- CDC Advisory Committee on Immunization Practices ...

Like everything in health policy, it's complicated.

Today, we confront emerging threats from a range of respiratory viruses, insect-transmitted viruses, and viruses we have not ...

Kotsopoulos noted that BRCA carriers have a substantially increased lifetime risk of breast and ovarian cancer. Management of ...

Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...

The final Dec. 5 memo, according to FDA employees with knowledge of the situation, states that under an established World ...

The FDA on Thursday approved a transcranial direct current stimulation (tDCS) device as the first at-home non-drug therapy ...

In May 2018, andexanet was granted accelerated approval as the sole antidote on the market for the DOACs rivaroxaban (Xarelto ...

Sources tell CNN the FDA is planning to slap a black boxed warning on COVID vaccines -- the agency's most serious warning ...

True or False: A large observational study found that adults with diabetes who used GLP-1 receptor agonists had more ...

GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...